Jimmy  Darts

SB Mowing

Pattie Gonia

Little Miss Flint

Kalina Silverman / @makebigtalk on Instagram

The Dogist

Samuel Weidenhofer

Patriotic Kenny Foundation

Peter Bond

That Good News Girl

Ben Saunders - Flawless Cleaning

Flavor Flav

Ask Uncle Jack

Amy Jandrisevits

FowlMouthFarmer

Tess Bohne

Latonja and Taylor Richardson

Officer Richard Craig

John Wolfe

Khloe

<div>Sarah &amp; Eleonore Moll — Groningen, The Netherlands
</div>
<div>June 2026 · Funding request: €290,000 / $320,000 USD
</div>
<div><br />
</div>
<div>Dear Friends, Foundations, and Supporters,
</div>
<div><br />
</div>
<div>We are Sarah and Eleonore Moll, non-identical twins, born January 9, 2000, in Groningen, in the north of the Netherlands. We grew up in a family where respect for every human being, regardless of background, colour, or belief, was not a value taught but simply lived. We were raised to believe that each person has something meaningful to contribute, and that knowing what you can give, and giving it with conviction, is what makes a life worthwhile.
</div>
<div><br />
</div>
<div>We are writing to you today not for ourselves, but for the two people who built that foundation in us.
</div>
<div><br />
</div>
<div>In 2010, our mother Eveline, then 45 years old, was diagnosed with breast cancer. It arrived without warning and changed everything. What followed were surgeries, chemotherapy, and months of treatment. It was grueling. But our family held together, and so did she. We came through it, wiser than we wished to be, but deeply grateful for the care she received and the life that continued.
</div>
<div><br />
</div>
<div>Then in 2017, our father Maurice received an early diagnosis of rectal carcinoma. Once again, the early detection was a gift, and once again, we found ourselves on the other side , changed, but whole.
</div>
<div><br />
</div>
<div>These experiences shaped us. They taught us what matters. And they led both of us to work in ways that give something back, because we knew, firsthand, what it means to receive help when it counts most.
</div>
<div><br />
</div>
<div>We did not expect fate to come for our family a third time. But at the end of May 2026, within 24 hours of each other, both of our parents received new cancer diagnoses. This time, two rare and aggressive cancers. This time, the stakes are higher than anything we have faced before.
</div>
<div><br />
</div>
<div>Our father Maurice has been diagnosed with <strong>Stage 4 Metastatic Leiomyosarcoma (LMS)</strong>, a rare and aggressive soft tissue sarcoma located in the retroperitoneal region, behind the abdominal lining. He is currently under treatment at a leading university hospital in the Netherlands, where he is being cared for by an exceptional specialist team.
</div>
<div><br />
</div>
<div>Twenty-four hours later, our mother Eveline received her diagnosis: <strong>cholangiocarcinoma</strong>, a rare, aggressive tumor of the bile ducts within the liver. In her case, the tumor is located at the liver hilum (the junction where the left and right bile ducts exit the liver). She is also under treatment at the same university hospital, in the hands of a dedicated team of surgeons and gastroenterologists.
</div>
<div><br />
</div>
<div><strong>We have been through this before. We know what hope looks like, and how tears feel when they grow. We also know that for rare, aggressive cancers like these, the difference between good care and the best care in the world can be the difference between months and years.</strong>
</div>
<div><br />
</div>
<div>That is why we are reaching out! Please come to our aid.
</div>
<div><br />
</div>
<div>For our father, Maurice, we are exploring specialised treatment options, such as clinical trials, at hospitals and cancer centres in the United States and across Europe. We want every possible option on the table. Not because we have given up on the care he receives here in the Netherlands, but because we want to make sure we have explored every possible avenue and have not left any stone unturned.
</div>
<div><br />
</div>
<div><strong>Total funding sought for Maurice's treatment and specialist consultations:</strong>
</div>
<div><strong>€290,000 / $320,000 USD</strong>
</div>
<div><br />
</div>
<div>We are also exploring the possibilities for our mother Eveline, and we will pursue every avenue available to give both of our parents the best possible chance.
</div>
<div><br />
</div>
<div><strong>We want to be honest with you about something. We are not asking only for our family.</strong>
</div>
<div><br />
</div>
<div>Every patient who reaches such an institution, such as one in Houston, every case that is studied, every treatment plan that pushes at the edge of what is known, that knowledge does not disappear. It becomes part of the record. It informs the next patient, the next trial, the next breakthrough. We genuinely believe that supporting access to world-class care for rare cancer patients is not just an act of compassion , it is an investment in the future of medicine itself.
</div>
<div><br />
</div>
<div>If you can help us bring our father to the specialists who know his cancer best, you help him, and through him, you help everyone who comes after.
</div>
<div><br />
</div>
<div>We are two young women, 26 years old, standing in front of you with full hearts and clear eyes. We have not written this letter to make you feel sorry for us. We have written it because we believe in asking directly, honestly, and with purpose, just as we were taught.
</div>
<div><br />
</div>
<div>If there is any way you are able to support us, through a grant, a donation, a referral, or simply by sharing our story, we would be profoundly grateful!!!!
</div>
<div><br />
</div>
<div>Thank you for reading this far. Thank you for the work you do. And thank you, in advance, for any help you are able to offer.
</div>
<div><br />
</div>
<div>With respect and hope,
</div>
<div><br />
</div>
<div>Sarah Moll &amp; Eleonore Moll
</div>
<div>Groningen, The Netherlands · June 2026
</div>

Eleonore M

Eleonore M

What they care about

Featured causes

About me